Cyclic Cushing Syndrome Caused By An ACTH-Producing Pheochromocytoma

    October 2023 in “ Journal of the Endocrine Society ”
    Yetunde B Omotosho, Margaret E. Wierman, Khulood Bukhari, Karel Pacák, Raven McGlotten, Lynnette K. Nieman
    Image of study
    TLDR A woman's cyclic Cushing syndrome was caused by a tumor in her adrenal gland that produced ACTH.
    A 72-year-old female with a five-year history of cyclic symptoms consistent with Cushing syndrome (CS) was diagnosed with an adrenocorticotropic hormone (ACTH)-producing pheochromocytoma (Pheo). Her symptoms included weight fluctuations, hair loss, skin changes, emotional lability, and glucose intolerance. Biochemical tests revealed elevated levels of ACTH, cortisol, catecholamines, and chromogranin A. Imaging studies identified a right adrenal nodule, which was intensely active on PET/CT scans. The patient underwent successful right adrenalectomy, and the mass was confirmed to be a Pheo with ACTH production. Postoperative results showed normalized blood pressure and suppressed morning cortisol and ACTH levels, requiring physiological replacement with hydrocortisone and later prednisone. At a six-month follow-up, the patient's pituitary-adrenal axis remained suppressed. This case highlights the diagnostic challenge of cyclic CS and the importance of considering ACTH-producing Pheo in cases of ACTH-dependent hypercortisolism with an adrenal mass.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 137 results

      community Medications that cause extra hair growth

      in Research/Science  123 upvotes 1 year ago
      The post discusses the side effects of various drugs causing excess hair growth, questioning why only minoxidil is used in the hair loss industry. The conversation includes users sharing their experiences and concerns about potential side effects of these drugs, with some preferring baldness over potential health risks.

      community Breezula will hit the market in 2026, Cosmo Pharmaceuticals statement!

      in Product  52 upvotes 9 months ago
      Breezula, a hair loss treatment, is expected to cost around $100 a month and is anticipated to be released in 2026. The effectiveness of Breezula is debated, with some suggesting it loses effectiveness over time and others arguing it maintains hair compared to baseline.

      community 1.5 years on fin/min progress pics, thoughts would be great!

      in Progress Pictures  69 upvotes 3 years ago
      A 42-year-old male shared his 1.5-year hair regrowth progress using 1.25mg finasteride daily and regular doses of minoxidil twice a day, and recently started using the Derminator 2. He also mentioned his battle with cancer and Cushing's syndrome, which affected his weight and hair.

      community Damn...I've made some real progress, yeah??

      in Progress Pictures  992 upvotes 3 weeks ago
      A user shared their significant hair regrowth progress using topical minoxidil, oral finasteride, and minoxidil chews, while transitioning to generic versions. They also mentioned using batana oil and microneedling, with no side effects reported.

      community [25, F] [RANT] Shedding since March 2020. This just isn’t fair.

      in Female  42 upvotes 3 years ago
      User "missbloombastic" has been experiencing hair loss since 2016 and tried min, fin, multivitamins, and spiro with mixed results. Another user shares their struggle with hair loss and its impact on self-esteem, while a third user suggests checking blood tests and confirming the cause of hair loss.

    Similar Research

    5 / 1000+ results
      The Eye and the Skin in Endocrine Metabolic Diseases

      research The Eye and the Skin in Endocrine Metabolic Diseases

      10 citations, December 2015 in “Clinics in Dermatology”
      Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.
      Skin Manifestations of Endocrine Diseases

      research Skin Manifestations of Endocrine Diseases

      4 citations, January 2015 in “Türk Patoloji Dergisi”
      Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.
      Endocrine-Skin Interactions

      research Endocrine-Skin Interactions

      46 citations, July 1988 in “Journal of The American Academy of Dermatology”
      Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.
      Toward a Diagnostic Score in Cushing's Syndrome

      research Toward a Diagnostic Score in Cushing's Syndrome

      42 citations, November 2019 in “Frontiers in Endocrinology”
      The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.